Keros Therapeutics director buys $10,270 in company stock

uk.investing.com

Keros Therapeutics director Jean Jacques Bienaime purchased 1,000 shares of company stock on August 17, 2026, for a total of $10,270, with prices ranging from $10.02 to $10.39 per share. The purchase was made under a Rule 10b5-1 trading plan adopted on December 5, 2025. Following the transaction, Bienaime owns 19,592 shares. The stock trades near its 52-week low of $9.69, down 45% year-to-date. Keros maintains a strong current ratio of 21.96 and holds more cash than debt, though it is burning through cash quickly. The company recently appointed Anne Prener to its board of directors.


With a significance score of 1.1, this news ranks in the top 52% of today's 30006 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers:


Keros Therapeutics director buys $10,270 in company stock | News Minimalist